Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients
European Journal of Clinical Pharmacology2010Vol. 67(3), pp. 253–260
Citations Over TimeTop 18% of 2010 papers
Maud Berge, R. Guillemain, David‐Alexandre Trégouët, C. Amrein, V. Boussaud, P. Chevalier, Agnés Lillo‐Le Louët, Christine Le Beller, Pierre Laurent‐Puig, Philippe Beaune, Eliane M. Billaud, Marie‐Anne Loriot
Related Papers
- → Correlation of CYP2C19 Phenotype With Voriconazole Plasma Concentration in Children(2013)51 cited
- → A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis(2016)31 cited
- → Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians(2015)19 cited
- → Invasive Aspergillus Infection Requiring Lobectomy in a Cyp2C19 Rapid Metabolizer with Subtherapeutic Voriconazole Concentrations(2016)10 cited